Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
65.10
-1.74 (-2.60%)
Oct 17, 2025, 3:00 PM CST
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 433.20 billion as of October 17, 2025. Its market cap has increased by 51.50% in one year.
Market Cap
433.20B
Enterprise Value
397.63B
Revenue
30.15B
Ranking
n/a
PE Ratio
56.10
Stock Price
65.10
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.58B to 433.20B, an increase of 16,713.22%. That is a compound annual growth rate of 22.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 433.20B | 48.43% |
Dec 31, 2024 | 291.86B | 1.48% |
Dec 29, 2023 | 287.60B | 17.03% |
Dec 30, 2022 | 245.74B | -23.94% |
Dec 31, 2021 | 323.08B | -45.40% |
Dec 31, 2020 | 591.75B | 53.53% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
WuXi AppTec | 284.61B |
Shenzhen Mindray Bio-Medical Electronics | 272.72B |
Sichuan Biokin Pharmaceutical | 142.05B |
Zhangzhou Pientzehuang Pharmaceutical., | 118.46B |
Shanghai United Imaging Healthcare | 117.99B |
Aier Eye Hospital Group | 116.66B |
Yunnan Baiyao Group Co.,Ltd | 101.81B |
Shanghai Fosun Pharmaceutical (Group) | 72.06B |